In experiments performed on mouse models of melanoma to analyze the intratumoral immune microenvironment, mice that did not respond to anti-PD1 therapy had a significantly higher population of Tregs that shifted the CD8+/Treg ratio in an age-dependent manner. The gene discussed is CD8A; the disease is melanoma.